Principal Investigator
Frini Karayanidis
Behavioural Sciences Building
University Drive
Callaghan, NSW 2308
Australia
frini.karayanidis@newcastle.edu.au
Summary
Country | Australia |
---|---|
Principal Investigator | Frini Karayanidis |
Contact person (email) | frini.karayanidis@newcastle.edu.au |
Key publication/reference | |
Years in which study conducted | Recruitment 2017-2018 Follow-up (funding dependent) 2019-2020 |
Sample | |
Size | Target numbers: 120 |
Population: Hospital/community | Community |
Selection: consecutive/random | Consecutive |
Admit with previous stroke? | Yes |
Admit with TIA? | Yes |
Age range | 40-90yrs |
Number of centres | 1 |
Control group: number, population, selection | 50, healthy ageing, HMRI Volunteer Register |
Assessment | |
Initial: (when and what were the assessments?) | Post event: MedHX, VRF, CT 78%, MRI 39% |
First detailed assessment | 1-5y: NΨ, MRI, EEG, physiological, psychiatric |
Follow-ups | Follow-up (funding dependent) 2019-2020 |
Stroke-related data | MRI |
Functional tests/data | EEG during cognitive control tasks and at rest |
Other medical tests/data | BP, BMI, WHR |
Neuropsychological tests | NIH toolbox cognitive battery, TMT, MoCA |
MRI scans, when and how many | 2017 (1-5y post event): 43 T1, FLAIR and DWI |
PET scans | No |
Psychiatric exams/diagnoses | Depression and anxiety (HADS), quality of life (EQ-5D-3L) |
Dementia diagnosis criteria | MoCA <19 |
Intervention trialled? | No |
CT=computed tomography scan, MRI= magnetic resonance imaging, EEG= electroencephalogram, BP= blood pressure, BMI= body mass index, WHR = waist to hip ratio, TMT= trail making test, MoCA= Montreal Cognitive Assessment, HADS= hospital anxiety and depression scale, EQ-5D-3L= European quality of life scale, MedHx=medical history, VRF=vascular risk factors (hypertension, diabetes, atrial fibrillation, obesity, smoking etc.), NΨ=neuropsychological, TIA=transient ischemic attack, m=month, y=year